MARLVEL

Davis's Drug Guide - Nurses vs its rivals

Side-by-side comparison against Davis's Drug Guide - Nurses's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Davis's Drug Guide - Nurses
This App
Drugs.com Medication Guide
Nemesis
UpToDate
Contender
Medscape
Contender
Merck Manual Professional
Peer
Calculate by QxMD
Peer
Skyscape Medical Library
Peer
Pill Identifier by Drugs.com
New Kid
Core Identity
DeveloperUnbound Medicine, Inc.Drugs.comUpToDate, Inc.WebMDMerck & Co IncWebMDSkyscape Medpresso IncDrugs.com
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidAndroid, iOSAndroid, iOSiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOS, Android
Store Metrics
Rating4.9 / 54.8 / 53.7 / 53.6 / 54.8 / 54.8 / 54.8 / 53.4 / 5
Ratings Count8,94113,8545281,3819995,0862,969142
PriceFreeFreeFreeFreeFreeFreeFree$0.99
Release DateFeb 6, 2009Mar 1, 2013Apr 15, 2011Jul 16, 2009Sep 23, 2009Mar 20, 2010Apr 1, 2014Oct 21, 2010
Last UpdatedApr 3, 2026Apr 15, 2026Feb 24, 2026Apr 8, 2026Mar 13, 2026Dec 19, 2025Jan 30, 2026Apr 9, 2026
Sentiment & Reviews
Sentimentmixedpositiveterrible----negative
Score45/10065/10015/100----25/100
Praises
  • Succinct medication monographs provide reliable clinical reference for nursing students and practitioners
  • Integrated dosage and infusion calculators assist with critical medication safety checks
  • Medication Management & Information
  • Pill Identification
  • High quality clinical content remains the primary reason for long-term professional reliance
----
  • Utility for Identification
Complaints
  • Subscription and login errors prevent access to paid content across devices
  • Transition to a mandatory subscription model alienates users who previously accessed content via textbooks
  • Monetization & Pricing
  • Technical Issues & Access
  • Persistent application freezing during search and article loading renders the tool unusable
----
  • Inaccurate/Incomplete Database
  • Poor Search Functionality
Requests
  • Cross-platform license portability to allow access on multiple devices after purchase
-
  • Concise article summaries with optional links for atomic level detail
-----
Strategic Intel
Strengths
  • Integrated IV calculators function as a daily-use clinical retention loop
  • Exclusive DrugGuide.com web access creates a multi-surface professional workflow
  • Massive database of 24,000+ peer-reviewed medications
  • Highly-rated visual Pill Identifier tool
  • Strong consumer brand trust (25M monthly visitors)
  • Clinician-authored content functions as a high-switching-cost brand moat
  • Expert AI integration provides a premium-tier conversion lever
----
  • Drugs.com brand authority
  • AI-driven photo recognition
  • Integration with broader drug info ecosystem
Weaknesses
  • 0.06★ rating gap between iOS and Android indicates authentication instability
  • $39.99/year subscription model lacks a one-time purchase option for legacy users
  • Aggressive $8.99/mo subscription pricing causing user friction
  • Technical bugs in v3.1.51 (login failures, UI duplication)
  • Manual entry for pill ID vs emerging AI camera scanning
  • Persistent search-result freezing drives high churn risk
  • Offline mode failure prevents access in remote clinical settings
----
  • High $9.99/week subscription cost
  • Database gaps for common/generic drugs
  • Search UI bugs (disappearing filters)
Pricingsubscriptionfreemiumsubscriptionfreefreefreefreemiumfreemium
MomentumMaintenanceMaintenanceActiveIntenseActiveSteadyActive-
Update Cadence5 versions, 1 majors/6mo, ~53d avg5 versions, ~26d avg5 versions5 versions5 versions5 versions5 versions-

Compare Davis's Drug Guide - Nurses head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Davis's Drug Guide - Nurses, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

See methodologyContact support

Data licensed under CC-BY-NC 4.0